Jane Anne Salik
Director/Board Member bei POLYPEPTIDE GROUP AG
Vermögen: 657 773 $ am 31.03.2024
Profil
Jane Anne Salik is currently the Chief Executive Officer at PolyPeptide Laboratories (Sweden) AB, the Executive Director at PolyPeptide Laboratories Holding (PPL) AB, and the Non-Executive Director at PolyPeptide Group AG.
Previously, she held the position of Chief Executive Officer at PolyPeptide Laboratories A and President at PolyPeptide Laboratories, Inc. She also served as the Director at PolyPeptide Laboratories Holding BV and Vice President-Sales & Marketing at Bachem Americas, Inc. Additionally, she worked as the Manager-Product & Marketing at Roche Diagnostics Corp.
Dr. Salik obtained a doctorate degree from Stony Brook University in 1980 and an undergraduate degree from Lafayette College in 1975.
Bekannte Unternehmensbeteiligungen
| Unternehmen | Datum | Anzahl der Aktien | Bewertung | Datum der Bewertung |
|---|---|---|---|---|
POLYPEPTIDE GROUP AG
0,06% | 31.12.2022 | 19 553 ( 0,06% ) | 657 773 $ | 31.03.2024 |
Aktive Positionen von Jane Anne Salik
| Unternehmen | Position | Beginn |
|---|---|---|
| POLYPEPTIDE GROUP AG | Director/Board Member | 01.01.2006 |
PolyPeptide Laboratories (Sweden) AB
 PolyPeptide Laboratories (Sweden) AB BiotechnologyHealth Technology PolyPeptide Laboratories (Sweden) AB specializes in the production of proprietary peptides. The firm manufactures polypeptide, custom peptide Synthesis, peptide synthesis, and generic peptide. Its peptides products are part of several different pharmaceutical products. The company was founded in 1996 and is headquartered in Malmo, Sweden. | Chief Executive Officer | 01.09.1996 |
PolyPeptide Laboratories Holding (PPL) AB
 PolyPeptide Laboratories Holding (PPL) AB Financial ConglomeratesFinance PolyPeptide Laboratories Holding (PPL) AB manufactures commercial therapeutic peptides. The firm offers polypeptide, custom peptide synthesis, peptide synthesis, and generic peptide. The company was founded in 1996 and is headquartered in Malmo, Sweden. | Corporate Officer/Principal | - |
Ehemalige bekannte Positionen von Jane Anne Salik
| Unternehmen | Position | Ende |
|---|---|---|
PolyPeptide Laboratories Holding BV
 PolyPeptide Laboratories Holding BV Financial ConglomeratesFinance Part of Draupnir Corp. NV, PolyPeptide Laboratories Holding BV is an investment holding Dutch company. The private company is based in Hoofddorp, Netherlands. | Director/Board Member | 01.01.2021 |
PolyPeptide Laboratories, Inc.
 PolyPeptide Laboratories, Inc. Pharmaceuticals: MajorHealth Technology PolyPeptide Laboratories, Inc. manufactures proprietary and generic peptides. Its peptides technologies include liquid phase peptide synthesis, solid phase peptide synthesis, hybrid synthesis for larger scales and purification. The company is headquartered in Torrance, CA. | President | 01.01.2006 |
Bachem Americas, Inc.
 Bachem Americas, Inc. Pharmaceuticals: MajorHealth Technology Bachem Americas, Inc. engages in development of pharmaceutical ingredients through solid-phase peptide synthesis. The company is headquartered in Torrance, CA. | Sales & Marketing | 01.01.1996 |
Roche Diagnostics Corp.
 Roche Diagnostics Corp. Medical SpecialtiesHealth Technology Roche Diagnostics Corp. develops and manufactures diagnostic products. It offers anticoagulation management, blood gas and electrolytes, cholesterol and urinalysis products. The firm provides a broad portfolio of tools that help healthcare providers in the prevention, diagnosis and management of diseases like HPV, HIV, heart failure and diabetes, as well as other medical conditions, such as fertility and blood coagulation. Its products and services uses by researchers, physicians, patients, hospitals and laboratories worldwide. The company was founded in 1964 by Willard Eason and is headquartered in Indianapolis, IN. | Sales & Marketing | - |
PolyPeptide Laboratories A/S
 PolyPeptide Laboratories A/S Chemicals: SpecialtyProcess Industries PolyPeptide Laboratories A/S manufactures polypeptides and custom peptide synthesis. It offers custom research grade, good manufacturing practice-grade, therapeutic, generic and radiolabeled peptides. The company was founded in 2004 and is headquartered in Hillerod, Denmark. | Chief Executive Officer | - |
Ausbildung von Jane Anne Salik
| Stony Brook University | Doctorate Degree |
| Lafayette College | Undergraduate Degree |
Erfahrungen
Besetzte Positionen
Aktive
Inaktive
Börsennotierte Unternehmen
Private Unternehmen
Beziehungen
Beziehungen ersten Grades
Unternehmen ersten Grades
Herr
Frau
Aufsichtsräte
Führungskräfte
Unternehmensverbindungen
| Börsennotierte Unternehmen | 1 |
|---|---|
| POLYPEPTIDE GROUP AG | Health Technology |
| Private Unternehmen | 7 |
|---|---|
Roche Diagnostics Corp.
Roche Diagnostics Corp. Medical SpecialtiesHealth Technology Roche Diagnostics Corp. develops and manufactures diagnostic products. It offers anticoagulation management, blood gas and electrolytes, cholesterol and urinalysis products. The firm provides a broad portfolio of tools that help healthcare providers in the prevention, diagnosis and management of diseases like HPV, HIV, heart failure and diabetes, as well as other medical conditions, such as fertility and blood coagulation. Its products and services uses by researchers, physicians, patients, hospitals and laboratories worldwide. The company was founded in 1964 by Willard Eason and is headquartered in Indianapolis, IN. | Health Technology |
PolyPeptide Laboratories, Inc.
PolyPeptide Laboratories, Inc. Pharmaceuticals: MajorHealth Technology PolyPeptide Laboratories, Inc. manufactures proprietary and generic peptides. Its peptides technologies include liquid phase peptide synthesis, solid phase peptide synthesis, hybrid synthesis for larger scales and purification. The company is headquartered in Torrance, CA. | Health Technology |
PolyPeptide Laboratories Holding BV
PolyPeptide Laboratories Holding BV Financial ConglomeratesFinance Part of Draupnir Corp. NV, PolyPeptide Laboratories Holding BV is an investment holding Dutch company. The private company is based in Hoofddorp, Netherlands. | Finance |
Bachem Americas, Inc.
Bachem Americas, Inc. Pharmaceuticals: MajorHealth Technology Bachem Americas, Inc. engages in development of pharmaceutical ingredients through solid-phase peptide synthesis. The company is headquartered in Torrance, CA. | Health Technology |
PolyPeptide Laboratories Holding (PPL) AB
PolyPeptide Laboratories Holding (PPL) AB Financial ConglomeratesFinance PolyPeptide Laboratories Holding (PPL) AB manufactures commercial therapeutic peptides. The firm offers polypeptide, custom peptide synthesis, peptide synthesis, and generic peptide. The company was founded in 1996 and is headquartered in Malmo, Sweden. | Finance |
PolyPeptide Laboratories A/S
PolyPeptide Laboratories A/S Chemicals: SpecialtyProcess Industries PolyPeptide Laboratories A/S manufactures polypeptides and custom peptide synthesis. It offers custom research grade, good manufacturing practice-grade, therapeutic, generic and radiolabeled peptides. The company was founded in 2004 and is headquartered in Hillerod, Denmark. | Process Industries |
PolyPeptide Laboratories (Sweden) AB
PolyPeptide Laboratories (Sweden) AB BiotechnologyHealth Technology PolyPeptide Laboratories (Sweden) AB specializes in the production of proprietary peptides. The firm manufactures polypeptide, custom peptide Synthesis, peptide synthesis, and generic peptide. Its peptides products are part of several different pharmaceutical products. The company was founded in 1996 and is headquartered in Malmo, Sweden. | Health Technology |
